A critical assessment of the estrogenic potency of benzyl salicylate.
Toxicol Rep
; 8: 1002-1007, 2021.
Article
in En
| MEDLINE
| ID: mdl-34408969
4−OHT, 4-hydroxy-tamoxifen; ATCC, American Type Culture Collection; BPA, Bisphenol A; BS, Benzyl salicylate; Benzyl salicylate; CAT, chloramphenicol acetyl transferase gene; CoRAP, Community Rolling Action Plan; DMEM, Dulbecco's Modified Eagle Medium; DMSO, Dimethyl sulfoxide; E2, 17ß-estradiol; ER, estrogen receptor; ERE, estrogen response element; Estrogen receptor; FBS, foetal bovine serum; HEPES, N-2-hydroxyethylpiperazine-N-ethanesulfonic acid; HRPT, Human Relevant Potency Threshold; MCF7 proliferation assay; MoA, Mode of action; NOAEL, no observed adverse effect level; OECD, Organisation of Economic Co-operation and Development; Potency; REACH, Registration, Evaluation, Authorisation and Restriction of Chemicals; Reporter assay; SCCS, European Scientific Committee for Consumer Safety: SRB, sulforhodamine B; Substance evaluation; TG, test guideline; YES, Yeast Estrogen screen
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Toxicol Rep
Year:
2021
Document type:
Article
Affiliation country:
Suiza
Country of publication:
Irlanda